Neutrophil Extracellular Traps in Arterial and Venous Thrombosis
- PMID: 30634198
- DOI: 10.1055/s-0038-1677040
Neutrophil Extracellular Traps in Arterial and Venous Thrombosis
Abstract
Thrombotic complications are still a major health risk worldwide. Our view on the pathophysiology of thrombosis has significantly changed since the discovery of neutrophil extracellular traps (NETs) and their prothrombotic characteristics. Generated by neutrophils that release their decondensed chromatin as a network of extracellular fibers, NETs promote thrombus formation by serving as a scaffold that activates platelets and coagulation. The thrombogenic involvement of NETs has been described in various settings of thrombosis, including stroke, myocardial infarction, and deep vein thrombosis. The aim of this review is to summarize existing evidence showing the presence of NETs in human thrombus material. Following an introduction on NETs and their role in thrombus formation, the authors address studies showing the presence of NETs in arterial or venous thrombi. In addition, they focus on potential novel therapeutic opportunities to resolve or prevent thrombosis by targeting NETs.
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Conflict of interest statement
E.L. has no conflict of interest to disclose. S.F.D.M. and K.M. are inventors on the granted patent US9642822 covering the targeting of NETs in thrombosis. K.M. is an inventor on U.S. patent application 62/594,266 that covers the use of ruxolitinib and inhibition of JAK-STAT signaling to inhibit the formation of NETs.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases